TrialBone marrow transplantation2010

Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization.

G Tricot et al.PubMed ↗Publisher ↗

No numbers read from the abstract.